Life sciences companies commit to fight against COVID-19 pandemic with Bill & Melinda Gates Foundation
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
Mateon reported positive results for multiple COVID-19 drug candidates
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and sell the assay in Europe
On Mar. 25, 2020, Quidel received CE Mark for the Lyra SARS-CoV-2 assay, authorizing Quidel to market and…
Vir Biotech proceeded with two clinical development candidates for COVID-19
On Mar. 25, 2020, Vir Biotech announced announced that it has identified multiple human monoclonal antibody (mAb) development…
Xencor and Vir Biotech announced license agreement for use of Xtend XmAb antibody technology to treat COVID-19
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
The Jackson Laboratory expediting unique transgenic mouse model for COVID-19 research
On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…
CHF Solutions announced COVID-19 patients treated with Aquadex therapy for fluid management with Coronavirus treatment
On Mar. 25, 2020, CHF Solutions announced the use of its Aquadex therapy in the treatment of patients…
Merck donated 300,000 masks to New Jersey for COVID-19 emergency response
On Mar. 25, 2020, Merck announced it had donated 300,000 masks to New Jersey’s Office of Homeland Security…
Penn’s Perelman School of Medicine launched Coronavirus research center
On Mar. 25, 2020, the Perelman School of Medicine at the University of Pennsylvania announced it had established…
Mylan waives US marketing exclusivity for Lopinavir/Ritonavir to ensure availability for COVID-19 patient needs
On Mar. 25, 2020, Mylan announced that it had waived its exclusive rights in the U.S. to distribute…
City of Hope researchers developing COVID-19 vaccine
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
Resverlogix clinical candidate apabetalone featured as potential COVID-19 treatment in publication
On Mar. 24, 2020, Resverlogix announced a Mar. 23, 2020 bioRxiv publication that has shown apabetalone to inhibit…
U of A research projects shared $58 million in federal funding
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
3M partnered with Ford to help further accelerate COVID-19 response
On Mar. 24, 2020, 3M and Ford Motor announced a partnership to increase the production of 3M’s powered…
Bausch Health donated products and supplies in response to COVID-19 pandemic
On Mar. 24, 2020, Bausch Health announced it had donated medicines and health care products to assist in…
COVID-19 | Diagnostics | FDA
FDA provided Emergency Use Authorization to PerkinElmer for COVID-19 testing
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
Patients with severe Coronavirus disease could offer clues to treatment
On Mar. 24, 2020, a new international project aims to enroll 500 COVID-19 patients to search for genetic…
Oxford University’s COVID-19 research received government funding
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
Biotechnology | COVID-19 | Diagnostics | FDA
bioMerieux received FDA Emergency Use Authorization for BIOFIRE COVID-19 test
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
Dynavax and Clover Biopharmaceuticals announced COVID-19 research collaboration
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announceda research collaboration…
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, announced government grant to fund bispecific antibody development platform
On Mar. 24, 2020, aTyr Pharma announced announced that the companyﾒs Hong Kong subsidiary, Pangu BioPharma, together with…
Mesa Biotech received Emergency Use Authorization from FDA for 30 minute point ofcCare molecular COVID-19 test
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the FDA for…
BioSig subsidiary NeuroClear acquired license for a broad-spectrum anti-viral agent that may treat COVID-19
On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop…
UNMC/Nebraska Medicine pioneering method to reuse personal protective equipment
On Mar. 24, 2020, Nebraska Medicine has developed a safe and effective method to decontaminate single-use personal protective…
Agriculture | Biotechnology | Disease | Therapeutics | USDA | Veterinary
MatMaCorp’s DNA and RNA testing platform could help protect the U.S. pork supply from African swine fever
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
BioReference Laboratories and City of Miami provided testing for Coronavirus Disease 2019
On Mar. 24, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the City of Miami…
Emerald Organic and Todos Medicalfor JV to supply USwith COVID-19 rapid point-of-care testing kits
On Mar. 24, 2020, Emerald Organic Products and Todos Medical announced the creation of Corona Diagnostics, LLC, a…
$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
Ology Bioservices, Inovio partnered to manufacture COVID-19 DNA vaccine with $11.9 million DoD grant
On Mar. 24, 2020, Ology Bioservices and Inovio Pharma announced the Department of Defense (DOD) has awarded Ology…
Windtree announced clinical study of lung injury treatment in COVID-19 patients with its KL4 surfactant therapy
On Mar. 24, 2020, Windtree Therapeutics announced it will study its proprietary KL4 surfactant to potentially mitigate the…